Eli Health Raises $3.6 Million To Improve Women’s Health With Saliva-Based Continuous Hormone-Monitoring Technology

Hormone fluctuations affect a broad range of conditions, transitions, and symptoms experienced by women from puberty to post-menopause. These fluctuations impact not only menstrual cycles but also various aspects of women’s physical and mental health. Apart from being related to reproductive health – menopause, fertility, and contraception, hormones are behind endocrine conditions, which means that hormones impact much […]

These 3 Women Are Shaping The Future Of Women’s Health By Bringing Next Generation Of Femtech Products To The Market

It’s not a secret that finally, after years of being overlooked, women’s health is having its moment. According to Frost & Sullivan’s report, the femtech (female technology) market revenue is expected to reach $1.1 billion by 2024, growing at a compound annual growth rate (CAGR) of 12.9%. The report states that, through solutions targeting early diagnosis and leveraging […]

Eli Raises $1.9 Million CAD in Seed Funding to Develop At-Home Hormone Monitoring Tech

Eli Science Inc. has raised a $1.9 million CAD ($1.5 million USD) seed round to target the historically underserved women’s healthtech market via its saliva-based daily hormone tracking technology. The round, which was co-led by Hong Kong’s Vectr Ventures and 2048 Ventures, closed in late December 2020. Other investors included Real Ventures, Techstars, Panache Ventures, Ramen Ventures, MEDTEQ+, and Steven Arless, who joined Eli […]

Our website uses cookies to ensure you get the best experience. Learn More